Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.

Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.

<h4>Objective</h4>The aim of this study was to assess the seroconversion rate and percent inhibition of neutralizing antibodies against the wild-type and Omicron variants of SARS-CoV-2 in patients with solid cancer who received two COVID-19 vaccine doses by comparing chemotherapy and non...

Full description

Saved in:
Bibliographic Details
Main Authors: Busyamas Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Nuttaphoom Nuchpong, Apichat Tantraworasin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0310781
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0310781

Similar Items